Stay updated on LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Sign up to get notified when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.

Latest updates to the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page
- Check5 days agoChange DetectedThe page now displays the EMBER study record for LY3484356, including its cancer indications, study design, participant criteria, treatment arms, outcomes, and locations. The record indicates the study is active but no longer recruiting.SummaryDifference100%

- Check12 days agoChange DetectedThe page no longer displays the 403 Forbidden message and instead shows the ClinicalTrials.gov site shell, with its revision label updated from v3.7.2 to v3.8.0. Study details are not visible.SummaryDifference0.8%

- Check19 days agoChange DetectedA site-wide banner announces NIH website updates and says agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence.”SummaryDifference1%

- Check26 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check33 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check54 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previous study record with a generic error screen and site chrome. The detailed study content and related metadata have been removed, effectively making the study unviewable on this page.SummaryDifference20%

Stay in the know with updates to LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LY3484356 in Advanced Breast or Endometrial Cancer Clinical Trial page.